Literature DB >> 6205927

Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patients.

S Hirohashi, M Watanabe, Y Shimosato, T Sekine.   

Abstract

A monoclonal antibody, ST-4-39, was obtained by means of a unique immunization procedure using a gastric cancer xenograft as an immunogen. ST-4-39 reacted immunohistochemically with various cancers and a limited number of normal tissues. The antigen reactive with ST-4-39 was detected in sera of cancer patients, and possessed a molecular weight of greater than or equal to 1 X 10(6). The antigenic determinant was a sialyl-sugar residue different from sialyl-Lewis a recognized by NS 19-9.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205927

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  13 in total

1.  A Case of Breast Cancer Metastatic to the Pituitary Gland.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

2.  Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis.

Authors:  Yoshinori Ino; Masahiro Gotoh; Michiie Sakamoto; Kiyomi Tsukagoshi; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Serum levels of NCC-ST-439 in Dukes' C colorectal cancer patients: a preliminary report.

Authors:  K Matsumoto; T Kinoshita; T Ishida; H Itoh; C Miki; H Suzuki
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Abstracts of selected papers: 28th annual meeting of the Japanese Society of Gastroenterology. Kanazawa, Japan, October 1-3, 1986.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1987-06

5.  Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer.

Authors:  H Iwase; S Kobayashi; Y Itoh; H Fukuoka; T Kuzushima; H Iwata; T Yamashita; A Naitoh; K Itoh; A Masaoka
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Production, cross reactivity, and epitope analysis of monoclonal antibodies against rat kidney gamma glutamyltransferase.

Authors:  J Bayad; N Sabolovic; D Bagrel; A Visvikis; M Wellman; G Siest
Journal:  Cell Biol Toxicol       Date:  1990-04       Impact factor: 6.691

7.  Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.

Authors:  Kan Yonemori; Noriyuki Katsumata; Ayako Noda; Hajime Uno; Mayu Yunokawa; Eriko Nakano; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Kenji Tamura; Masahiro Takeuchi; Yasuhiro Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-05       Impact factor: 4.553

Review 8.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

9.  CAXII Is a sero-diagnostic marker for lung cancer.

Authors:  Makoto Kobayashi; Toshihide Matsumoto; Shinichiro Ryuge; Kengo Yanagita; Ryo Nagashio; Yoshitaka Kawakami; Naoki Goshima; Shi-Xu Jiang; Makoto Saegusa; Akira Iyoda; Yukitoshi Satoh; Noriyuki Masuda; Yuichi Sato
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

10.  Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion.

Authors:  K Honda; T Yamada; R Endo; Y Ino; M Gotoh; H Tsuda; Y Yamada; H Chiba; S Hirohashi
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.